Anxiety and fear of dental anesthesia.
Conditions
Interventions
Intervention 1: Intervention group: Performing EMDR psychological technique Through bilateral stimulation of the brain hemispheres with alternating hand movements and playing with the child by creatin
Sponsors
Tehran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
6 Years to 10 Years
Inclusion criteria
Inclusion criteria: Need for dental treatment under local anesthesia Presence of anxiety or history of unpleasant dental treatment Moderate to severe primary anxiety based on Visual Facial Anxiety Scale (VFAS) Absence of mental problem and personality disorder
Exclusion criteria
Exclusion criteria: Presence of systemic disease Any allergy to the anesthetic Use of painkillers and painkillers in the last 24 hours
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The level of anxiety is measured and recorded using the MCDAS (Modified Child Dental Anxiety Scale) anxiety questionnaire. Timepoint: The level of pain and anxiety is measured by indicators before and after the anesthetic injection. Method of measurement: The MCDAS anxiety questionnaire has been translated into Persian and has good validity and reliability. It consists of 8 questions that are asked to the patient, and the patient must choose the answers to the questions from a five-option Likert scale (complete calm, little fear, moderate, high and very high). In this way, the maximum score for each individual on this questionnaire is 40 and the minimum is 8. | — |
Secondary
| Measure | Time frame |
|---|---|
| Pain level. Timepoint: before and after injection. Method of measurement: The VFAS index consists of six faces, increasing in size from left to right. The first face is without anxiety and the last face from the right indicates the highest anxiety.;Pain level. Timepoint: during injection. Method of measurement: The FLACC index is recorded by an observer and consists of five sections: face, legs, activity, crying, and consalibility Each section is scored and measured at the end.;Heart rate level. Timepoint: Before, during and after injection. Method of measurement: Using a pulse oximeter. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSara ghadimi
Tehran University of Medical Sciences
Outcome results
None listed